Vladimir V. Koval

Dr. Vladimir V. Koval

Institute of Chemical Biology and Fundamental Medicine, Novosibirsk, Novosibirskaya Oblast’, Russia
orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2005 in Nucleic Acids Research
Verified
Journal Article
Open access
Nikita A. KuznetsovNikita A. Kuznetsov
Nikita A. Kuznetsov
VKVladimir V. Koval
Vladimir V. Koval
DZDmitry O Zharkov
Dmitry O Zharkov
GNGeorgy A Nevinsky
Georgy A Nevinsky
KDKenneth T Douglas
Kenneth T Douglas
OFOlga S. Fedorova
Olga S. Fedorova
Human 8-oxoguanine-DNA glycosylase (hOgg1) excises 8-oxo-7,8-dihydroguanine (8-oxoG) from damaged DNA. We report a pre-steady-state kinetic analysis of hOgg1 mechanism using stopped-flow and enzyme fluorescence monitoring. The kinetic scheme for hOgg1 processing an 8-oxoG:C-containing substrate was found to include at least three fast equilibrium steps followed by two slow, irreversible steps and another equilibrium step. The second irreversible step was rate-limiting overall. By comparing data from Ogg1 intrinsic fluorescence traces and from accumulation of products of different types, the irreversible steps were attributed to two main chemical steps of the Ogg1-catalyzed reaction: cleavage of the N-glycosidic bond of the damaged nucleotide and beta-elimination of its 3'-phosphate. The fast equilibrium steps were attributed to enzyme conformational changes during the recognition of 8-oxoG, and the final equilibrium, to binding of the reaction product by the enzyme. hOgg1 interacted with a substrate containing an aldehydic AP site very slowly, but the addition of 8-bromoguanine (8-BrG) greatly accelerated the reaction, which was best described by two initial equilibrium steps followed by one irreversible chemical step and a final product release equilibrium step. The irreversible step may correspond to beta-elimination since it is the very step facilitated by 8-BrG.

19 December 2006 in Biochemistry
Verified
Journal Article
Closed access
Nikita A. KuznetsovNikita A. Kuznetsov
Nikita A. Kuznetsov
VKVladimir V. Koval
Vladimir V. Koval
DZDmitry O. Zharkov
Dmitry O. Zharkov
YVYuri N. Vorobjev
Yuri N. Vorobjev
GNGeorgy A. Nevinsky
Georgy A. Nevinsky
OFOlga S. Fedorova
Olga S. Fedorova

1 January 2007 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
Nikita A. KuznetsovNikita A. Kuznetsov
Nikita A. Kuznetsov
VKVladimir V. Koval
Vladimir V. Koval
GNGeorgy A. Nevinsky
Georgy A. Nevinsky
KDKenneth T. Douglas
Kenneth T. Douglas
DZDmitry O. Zharkov
Dmitry O. Zharkov
OFOlga S. Fedorova
Olga S. Fedorova
7,8-Dihydro-8-oxoguanine (8-oxoG) is one of the major DNA lesions formed by reactive oxygen species that can result in transversion mutations following replication if left unrepaired. In human cells, the effects of 8-oxoG are counteracted by OGG1, a DNA glycosylase that catalyzes excision of 8-oxoguanine base followed by a much slower β-elimination reaction at the 3′-side of the resulting abasic site. Many features of OGG1 mechanism, including its low β-elimination activity and high specificity for a cytosine base opposite the lesion, remain poorly explained despite the availability of structural information. In this study, we analyzed the substrate specificity and the catalytic mechanism of OGG1 acting on various DNA substrates using stopped-flow kinetics with fluorescence detection. Combining data on intrinsic tryptophan fluorescence to detect conformational transitions in the enzyme molecule and 2-aminopurine reporter fluorescence to follow DNA dynamics, we defined three pre-excision steps and assigned them to the processes of (i) initial encounter with eversion of the damaged base, (ii) insertion of several enzyme residues into DNA, and (iii) enzyme isomerization to the catalytically competent form. The individual rate constants were derived for all reaction stages. Of all conformational changes, we identified the insertion step as mostly responsible for the opposite base specificity of OGG1 toward 8-oxoG:C as compared with 8-oxoG:T, 8-oxoG:G, and 8-oxoG:A. We also investigated the kinetic mechanism of OGG1 stimulation by 8-bromoguanine and showed that this compound affects the rate of β-elimination rather than pre-excision dynamics of DNA and the enzyme.

13 February 2004 in Nucleic Acids Research
Verified
Journal Article
Closed access
VKVladimir V. Koval
Vladimir V. Koval
Nikita A. KuznetsovNikita A. Kuznetsov
Nikita A. Kuznetsov
DZDmitry O Zharkov
Dmitry O Zharkov
AIAlexander A. ISHCHENKO
Alexander A. ISHCHENKO
KDKenneth T Douglas
Kenneth T Douglas
OFOlga S. Fedorova
Olga S. Fedorova
Formamidopyrimidine-DNA-glycosylase (Fpg protein, MutM) catalyses excision of 8-oxoguanine (8-oxoG) and other oxidatively damaged purines from DNA in a glycosylase/apurinic/apyrimidinic-lyase reaction. We report pre-steady-state kinetic analysis of Fpg action on oligonucleotide duplexes containing 8-oxo-2'-deoxyguanosine, natural abasic site or tetrahydrofuran (an uncleavable abasic site analogue). Monitoring Fpg intrinsic tryptophan fluorescence in stopped-flow experiments reveals multiple conformational transitions in the protein molecule during the catalytic cycle. At least four and five conformational transitions occur in Fpg during the interaction with abasic and 8-oxoG-containing substrates, respectively, within 2 ms to 10 s time range. These transitions reflect the stages of enzyme binding to DNA and lesion recognition with the mutual adjustment of DNA and enzyme structures to achieve catalytically competent conformation. Unlike these well-defined binding steps, catalytic stages are not associated with discernible fluorescence events. Only a single conformational change is detected for the cleavable substrates at times exceeding 10 s. The data obtained provide evidence that several fast sequential conformational changes occur in Fpg after binding to its substrate, converting the protein into a catalytically active conformation.

18 December 2019 in Chemistry – A European Journal
Verified
Journal Article
Closed access
PDF file
VTVictor M. Tormyshev
Victor M. Tormyshev
Alexey ChubarovAlexey Chubarov
Alexey Chubarov
OKOlesya Krumkacheva
Olesya Krumkacheva
DTDmitry V. Trukhin
Dmitry V. Trukhin
OROlga Yu Rogozhnikova
Olga Yu Rogozhnikova
Elena BagryanskayaElena Bagryanskaya
Elena Bagryanskaya

10 January 2002 in Biochemistry
Verified
Journal Article
Closed access
OFOlga S. Fedorova
Olga S. Fedorova
GNGeorgy A. Nevinsky
Georgy A. Nevinsky
VKVladimir V. Koval
Vladimir V. Koval
AIAlexander A. ISHCHENKO
Alexander A. ISHCHENKO
NVNataly L. Vasilenko
Nataly L. Vasilenko
KDKenneth T. Douglas
Kenneth T. Douglas